
To evaluate the efficacy and safety of zzso for central zzso zzso zzso zzso in patients with zzso 

An zzso zzso prospective study was zzso zzso zzso zzso was instilled into each zzso zzso with a dwell time of 30 minutes in patients with cancer with a dysfunctional zzso If the function of the zzso was not restored in 30 minutes, an additional dwell time of 30 minutes was allowed (a total of 60 minutes possible dwell time for the first zzso A second dose was repeated at 60 minutes after the first dose if zzso function was not restored (a total of 120 minutes for up to two zzso The primary efficacy outcome was the restoration of zzso zzso 

Of 139 patients who received zzso the zzso success rate after a 30-minute dwell time was zzso The cumulative success rates at 60, 90, and 120 minutes were zzso zzso and zzso zzso The variation of patient age, zzso age, zzso zzso age, zzso type, number of zzso or zzso type was not associated with the efficacy of zzso There were no zzso adverse events reported during the study zzso 

zzso at zzso dosing per zzso zzso is an effective and safe alternative that rapidly restores the zzso of zzso zzso in patients with zzso 

